PROCEPT BioRobotics (PRCT) Return on Capital Employed (2021 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly Return on Capital Employed came in at 25.13% in Q1 2026, down 481.0% year-on-year from 6.59% in Q1 2025, and down 7.41% on a QoQ basis from 23.39% in Q4 2025.
PROCEPT BioRobotics (PRCT) Return on Capital Employed (2021 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has 6 years of Return on Capital Employed data on file, last reported at 25.13% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 481.0% year-over-year to 25.13% in Q1 2026; TTM through Mar 2026 was 25.13%, a 481.0% decrease from a year earlier, with the FY2025 full-year figure at 22.81%, up 40.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 25.13%, down from 23.39% in the prior quarter.
- Over the last five years, Return on Capital Employed for PRCT reached as high as 18.63% in Q1 2022 and fell as low as 41.71% in Q2 2023.
- Historically, Return on Capital Employed has averaged 27.28% across 5 years, with a median of 25.13% in 2026.
- Across the five-year window, Return on Capital Employed slumped 2045 bps in 2023 and jumped 1302 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 28.69% in 2022, then decreased by 4 bps to 29.75% in 2023, then gained by 19 bps to 24.1% in 2024, then increased by 3 bps to 23.39% in 2025, then retreated by 7 bps to 25.13% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 25.13% in Q1 2026, 23.39% in Q4 2025, and 20.19% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 8.38% |
| 10 | PROCEPT BioRobotics | 994.59 Mn | 748.95 Mn | 53.95 Mn | -25.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.13% |
| Dec 31, 2025 | -23.39% |
| Sep 30, 2025 | -20.19% |
| Jun 30, 2025 | -19.67% |
| Mar 31, 2025 | -20.31% |
| Dec 31, 2024 | -24.10% |
| Sep 30, 2024 | -33.21% |
| Jun 30, 2024 | -32.65% |
| Mar 31, 2024 | -30.53% |
| Dec 31, 2023 | -29.75% |
| Sep 30, 2023 | -34.26% |
| Jun 30, 2023 | -41.71% |
| Mar 31, 2023 | -35.33% |
| Dec 31, 2022 | -28.69% |
| Sep 30, 2022 | -24.99% |
| Jun 30, 2022 | -21.26% |
| Mar 31, 2022 | -18.63% |
| Dec 31, 2021 | -16.51% |